References
Richards, D. M., Heel, R. C., Brogden, R. N., Speight, T. M., Avery, G. S.: Ceftriaxone: A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs 1984, 27: 469–527.
Femandes, C. J., Stevens, D. A., Murray, S. I., Ackerman, V. P.: An evaluation of recently developed antibiotics. Journal of Antimicrobial Chemotherapy 1983, 12: 577–85.
Grimm, H.: Susceptibility of bacterial pathogens to cefotetan judged by MIC and disc tests. Journal of Antimicrobial Chemotherapy 1983, 11, Supplement A: 37–43.
Harris, A. M., Plested, S. J., Harper, P. B.: A comparison of the in vitro properties of ceftazidime with those of new broad spectrum cephalosporins and gentamicin. Journal of Antimicrobial Chemotherapy 1981, 8, Supplement B: 43–45.
Reeves, D. S., Holt, H. A., Bywater, M. J., Bidwell, J. L.: Comparative in vitro activity of piperacillin. Journal of Antimicrobial Chemotherapy 1982, 9, Supplement B: 59–74.
Squires, E., Cleeland, R., Christenson, J., Boehni, E.: Interpretation of susceptibility of ceftriaxone. American Journal of Medicine 1984, 77: 12–16.
Mitsuhashi, S., Sekine, Y., Arisawa, M., Inoue, M., Ohshima, J., Maruyama, H. B.: Ceftriaxone (Ro 13-9904), a long-lasting cephalosporin: further studies on the mode of antibacterial action. Current Chemotherapy and Immunotherapy 1981, 1: 445–446.
McNamara, P. J., Stoeckel, K., Ziegler, W. H.: Pharmacokinetics of ceftriaxone following intra-venous administration of a 3g dose. European Journal of Clinical Pathology 1982, 22: 71–75.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Emmerson, A.M., Lamport, P.A., Reeves, D.S. et al. Ceftriaxone: A three centre comparative in vitro susceptibility study. Eur. J, Clin. Microbiol. 4, 142–144 (1985). https://doi.org/10.1007/BF02013584
Issue Date:
DOI: https://doi.org/10.1007/BF02013584